Premium
Porcine Pancreatic Islets: Isolation, Microencapsulation, and Xenotransplantation
Author(s) -
Sun YiLu,
Ma Xiaojun,
Zhou Daobiao,
Vacek Ivan,
Sun Anthony M.
Publication year - 1993
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/j.1525-1594.1993.tb00622.x
Subject(s) - xenotransplantation , islet , isolation (microbiology) , pancreatic islets , medicine , biology , diabetes mellitus , transplantation , bioinformatics , endocrinology
To provide a plentiful source of pancreatic islets for future clinical transplants into diabetic patients, we have developed a simple and reliable method to isolate porcine islets of a high degree of purity. Porcine pancreata were perfused and digested with collagenase, and the islets were then purified on dextran density gradients. In order to avoid any damage to the islets, no mechanical devices nor any strenuous treatment was employed. As many as 5 times 10 5 islets were isolated from a single porcine pancreas. Islets were encapsulated in alginate‐polylysine‐alginate membranes with the aid of an electrostatic droplet generator. In vitro studies demonstrated that the isolated islets secreted insulin in response to glucose and 3‐isobutyl‐L‐methylxanthine (IBMX) challenge for at least 4 weeks. Perifusion studies showed that the kinetics of insulin release from the encapsulated islets was similar to that exhibited by free islets. In in vivo studies, 18 diabetic BALB‐c mice were transplanted with 1,500‐2,500 encapsulated islets each. In 13 recipients, the diabetic condition was reversed for at least 85 days. When capsules were removed from 2 transplant recipients, their diabetic condition quickly recurred.